Experience
Oversaw due diligence for one of the world’s largest chemical companies during the acquisition of another company, including overseeing the mapping and analysis of the target’s patent portfolio and analyzing potential infringement by competitors.
Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Intellia Therapeutics, Inc.
Eastman Chemical Company & Others v. Covr Group Limited & Another
Eastman Chemical Company & Others
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.